Related Experiment Video
Updated: Jul 9, 2026

Dual Test Gas Pulmonary Diffusing Capacity Measurement During Exercise in Humans Using the Single-Breath Method
Published on: February 2, 2024
The effect of tiotropium on the pulmonary diffusing capacity
1Department of Chest Diseases, Cumhuriyet University Medical School, Sivas, Turkey. gonlugur@gmail.com
Abstract:
To our knowledge, there is no data on the effect of tiotropium on pulmonary gas exchange in healthy subjects. The aim of this study was to assess the effects of tiotropium on pulmonary diffusing capacity. Twenty-one healthy volunteers were enrolled for a prospective, randomized, double-blind, placebo-controlled study. Spirometric measurements, including pulmonary-diffusing capacity, were obtained before and after inhalation of drug or placebo. There was a significant decrease in forced vital capacity (FVC) and, consequently, an increase in the forced expiratory volume in one second (FEV1) to FVC ratio after placebo inhalation (p < 0.05), but no changes were found for percent-predicted FVC, FEV1, percent-predicted FEV1, percent-predicted forced expiratory flow (FEF25%-75%), percent-predicted peak expiratory flow (PEF), diffusing capacity of the lung for carbon monoxide (DLCO), single-breath alveolar volume (VA) and DLCO/VA ratio when compared with the baseline. Tiotropium inhalation caused a significant increase in FVC, percent-predicted FEV1, FEV1/FVC and percent-predicted FEF25%-75%, although the decrease in DLCO was insignificant (12.4 +/- 0.9 to 11.4 +/- 0.9). In conclusion, tiotropium does not change the pulmonary-diffusing capacity in healthy volunteers.
Insights
Tiotropium did not alter pulmonary diffusing capacity in healthy individuals. This study found no significant changes in lung function parameters like diffusing capacity of the lung for carbon monoxide (DLCO) after tiotropium inhalation.
Area of Science:
- Pulmonary Medicine
- Respiratory Physiology
- Pharmacology
Background:
- Pulmonary gas exchange and diffusing capacity are critical for respiratory health.
- Tiotropium is a long-acting muscarinic antagonist primarily used in COPD management.
- Data on tiotropium's effects on pulmonary function in healthy subjects is limited.
Purpose of the Study:
- To evaluate the impact of tiotropium on pulmonary diffusing capacity in healthy volunteers.
- To assess changes in spirometric parameters and gas exchange following tiotropium administration.
Main Methods:
- Prospective, randomized, double-blind, placebo-controlled study design.
- Inclusion of 21 healthy volunteers.
- Spirometry and pulmonary diffusing capacity measurements (DLCO, VA, DLCO/VA) pre- and post-inhalation of tiotropium or placebo.
Main Results:
- Placebo inhalation caused a significant decrease in forced vital capacity (FVC) and an increase in the FEV1/FVC ratio.
- Tiotropium inhalation resulted in significant increases in FVC, percent-predicted FEV1, FEV1/FVC, and percent-predicted FEF25%-75%.
- No significant changes in diffusing capacity of the lung for carbon monoxide (DLCO) or related parameters were observed with tiotropium.
Conclusions:
- Tiotropium does not significantly alter pulmonary diffusing capacity in healthy volunteers.
- The observed spirometric changes with tiotropium in healthy subjects differ from its effects in patients with obstructive lung diseases.
- Further research may be needed to fully elucidate tiotropium's respiratory effects across different populations.
Related Concept Videos
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
COPD: Management Using Bronchodilators and Corticosteroids
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
External and Internal Respiration
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
